Skip to main content
WeLoveTrump.com may receive compensation from affiliate partners for some links on the site. Read our full Disclosure here.

Did the CEO of Moderna Delete His Twitter Account and Dump $400 Million of Stock?


8,695 views

Rumors are flying online that the Moderna CEO deleted his Twitter account and sold $400 million of stock:

Let’s investigate, shall we?

I don’t go to the “Fact-Checking” (read: propaganda) websites to get my truth, but I do rely on them for one thing.

When even THEY admit certain elements of a story are true, then you know it is true, because it must be a truth so obvious and so true that even these people who twist and turn the truth for living couldn’t deny it.

And that’s what we have here.

The intrepid “fact checkers” over at USA Today “fact checked” this report and labeled it “Missing Context”.

But let’s examine what they conceded was true.

First, they admit his Twitter account is gone:

Bancel’s personal Twitter account was removed at some point prior to Feb. 11, and news reports and transaction records show he has been selling predetermined portions of Moderna shares on a weekly basis.

A message on Bancel’s Twitter page says, “This account doesn’t exist.” It is unclear why the account was deleted, but the most recent archive of his active page, captured in November 2021, shows he hadn’t used the platform since April 2019.

Next, they admit he did sell over $400 million in stock, but it was “over time”:

Records of Bancel’s Moderna stock sales from Insider Screener, Wall Mine and Yahoo Finance show he has sold shares every week, but he did not sell all of his holdings. He still owns 21.8 million shares of Moderna’s common stock as of Feb. 14, according to Forbes.

The SEC-tracking site SecForm4 says Bancel has sold $404 million of stock since November 2019.

During the week of Feb. 9, for example, Bancel sold 19,000 shares of Moderna at approximately $155 a share for $2.9 million. He sold another 19,000 shares the week prior for $3.1 million. There is no transaction listed for $400 million. The most shares he has ever sold at once was in February 2020, when he sold 33,134 units of Moderna for over $750,485, according to Wall Mine.

The SEC filings of the February sales say the transactions were made in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, which allows company insiders to set up predetermined sales to prevent insider trading. Bancel’s sales were part of a trading plan from December 2018 that was amended in September 2019 and May 2020.

I don’t know about you, but it sure looks to me like both of those things are confirmed true.

What do you think?

But that’s just the start…

Now let’s jump into another breaking report today from the DailyMail which alleges Moderna not only patented part of the COVID-19 gene sequence…but that they did it 3 years ago.

In other words, planned from the very beginning?

It’s beginning to look like that may be possible.

Absolutely stunning.

Take a look:

And here is Maria Bartiromo once again doing just about the ONLY journalism I can find in all of the so-called Mainstream Media:

Here’s more, from the Daily Mail:

Fresh suspicion that Covid may have been tinkered with in a lab emerged today after scientists found genetic material owned by Moderna in the virus’s spike protein.

They identified a tiny snippet of code that is identical to part of a gene patented by the vaccine maker three years before the pandemic.

It was discovered in SARS-CoV-2’s unique furin cleavage site, the part that makes it so good at infecting people and separates it from other coronaviruses.

The structure has been one of the focal points of debate about the virus’s origin, with some scientists claiming it could not have been acquired naturally.

The international team of researchers suggest the virus may have mutated to have a furin cleavage site during experiments on human cells in a lab.

They claim there is a one-in-three-trillion chance Moderna’s sequence randomly appeared through natural evolution.

But there is some debate about whether the match is as rare as the study claims, with other experts describing it as a ‘quirky’ coincidence rather than a ‘smoking gun’.

SARS-CoV-2, which causes Covid, carries all the information needed for it to spread in around 30,000 letters of genetic code, known as RNA. The virus shares a sequence of 19 specific letters with a genetic section owned by Moderna. Twelve of the shared letters make up the structure of Covid’s furin cleavage site, with the rest being a match with nucleotides on a nearby part of the genome

Moderna filed the patent in February 2016 as part of its cancer research division, records show. The patented sequence is part of a gene called MSH3 that is known to affect how damaged cells repair themselves in the body. It was approved on March 7 the following year

In the latest study, published in Frontiers in Virology, researchers compared Covid’s makeup to millions of sequenced proteins on an online database.

The virus is made up of 30,000 letters of genetic code that carry the information it needs to spread, known as nucleotides.

It is the only coronavirus of its type to carry 12 unique letters that allow its spike protein to be activated by a common enzyme called furin, allowing it to spread between human cells with ease.

Analysis of the original Covid genome found the virus shares a sequence of 19 specific letters with a genetic section owned by Moderna, which has a total of 3,300 nucleotides.

WHAT IS THE FURIN CLEAVAGE SITE?

SARS-CoV-2, which causes Covid, carries all the information needed for it to spread in around 30,000 letters of genetic code, known as RNA.

But it is the only coronavirus of its type to carry 12 unique letters that allow it to be activated by a common enzyme called furin.

This in turn makes the virus better at invading neighbouring cells.

The so-called furin cleavage site is located on the virus’ spike protein, the structure that binds to human cells in the first place.

Scientists sometimes add this element to lab viruses to make them more infectious, but in nature, pathogens can acquire it by swapping genetic code with other members of their family.

The furin has been the focal point of intrigue for many scientists studying the origins of the virus because no other known member of Covid’s family – a group called Sarbecoviruses – have the site.

The US-based pharmaceutical firm filed the patent in February 2016 as part of its cancer research division, records show.

The patented sequence is part of a gene called MSH3 that is known to affect how damaged cells repair themselves in the body.

Scientists have highlighted this pathway as a potential target for new cancer treatments.

Twelve of the shared letters make up the structure of Covid’s furin cleavage site, with the rest being a match with nucleotides on a nearby part of the genome.

Writing in the paper, led by Dr Balamurali Ambati, from the University of Oregon, the researchers said the matching code may have originally been introduced to the Covid genome through infected human cells expressing the MSH3 gene.

Professor Lawrence Young, a virologist at Warwick University, admitted the latest finding was interesting but claimed it was not significant enough to suggest lab manipulation.

He told MailOnline: ‘We’re talking about a very, very, very small piece made up of 19 nucleotides.

‘So it doesn’t mean very much to be frank, if you do these types of searches you can always find matches.

‘Sometimes these things happen fortuitously, sometimes it’s the result of convergent evolution (when organisms evolve independently to have similar traits to adapt to their environment).

‘It’s a quirky observation but I wouldn’t call it a smoking gun because it’s too small.

He added: ‘It doesn’t get us any further with the debate about whether Covid was engineered.’

And in case those videos get deleted from Twitter (which they have a chance to do), I found a backup.

Watch here on Rumble:

 



 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!